ABCG2 modulates chlorothiazide permeability in vitro-characterization of its interactions

Drug Metabolism and Pharmacokinetics

Volumn 27, Issue 3, 2012, Pages 349-353

  Beéry, Erzsébet ^a   Rajnai, Zsuzsanna ^a   Abonyi, Tibor ^a   Makai, Ildikó ^a   Bánsághi, Száva ^a   Erdõ, Franciska ^a   Sziráki, István ^a   Herédi Szabó, Krisztina ^a   Kis, Emese ^a   Jani, Márton ^a   Márki Zay, János ^a   Gabor Toth K ^b   Krajcsi, Péter ^a  

^a SOLVO BIOTECHNOLOGY   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

ABCG2 substrate; Absorption; Caco 2; Chlorothiazide; MDCKII BCRP; Probe for regulatory studies; Vesicular transport

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CHLOROTHIAZIDE; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2;

APICAL MEMBRANE; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; DRUG BIOAVAILABILITY; DRUG PENETRATION; DRUG PROTEIN BINDING; DRUG TRANSPORT; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; INTESTINE CELL; MEMBRANE VESICLE; NOTE; PROTEIN INTERACTION;

EID: 84863191353     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.DMPK-11-NT-068     Document Type: Article

References (15)

1. Novello, F. C. and Sprague, J. M.: Benzothiadiazine dioxides as novel diuterics. J. Am. Chem. Soc, 79: 2028-2029 (1957).
2. Miret, S., Abrahamse, L. and de Groene, E. M.: Comparison of in vitro models for the prediction of compound absorption across the human intestinal mucosa. J. Biomol. Screen., 9: 598-606 (2004).
3. Straughn, A. B., Melikian, A. P. and Meyer, M. C: Bioavailability of chlorothiazide tablets in humans. J. Pharm. Sci., 68: 1099-1102 (1979).
4. Brettell, H. R., Aikawa, J. K. and Gordon, G. S.: Studies with chlorothiazide tagged with radioactive carbon (C14) in human beings. Arch. Intern. Med., 106: 57-63 (1960).
5. Shugarts, S. and Benet, L. Z.: The role of transporters in the pharmacokinetics of orally administered drugs. Pharm. Res. 26: 2039-2054 (2009).
6. Grube M., Reuther S., Meyer Zu Schwabedissen H., Köck K., Draber K., Ritter C. A., Fusch C., Jedlitschky G. and Kroemer H. K.: Organic anion transporting polypeptide 2B1 and breast cancer resistance protein interact in the transepithelial transport of steroid sulfates in human placenta. Drug Metab. Dispos. 35: 30-35 (2007).
7. Jani, M., Szabó, P., Kis, E., Molnár, E., Glavinas, H. and Krajcsi P.: Kinetic characterization of sulfasalazine transport by human ATP-binding cassette G2. Biol. Pharm. Bull. 32: 497-499 (2009).
8. Rajnai, Z., Méhn, D., Beéry, E., Okyar, A., Jani, M., Tóth, G. K., Fülöp F., Lévi F. and Krajcsi P.: ATP-binding cassette B1 transports seliciclib (R-roscovitine), a cyclin-dependent kinase inhibitor. Drug Metab. Dispos. 38: 2000-2006 (2010).
9. Allen, J. D., van Loevezijn, A., Lakhai, J. M., van der Valk, M., van Tellingen, O., Reid, G., Schellens, J. H., Koomen, G. J. and Schinkel A. H.: Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Mol. Cancer Ther. 1: 417-425 (2002).
10. Osman M. A., Patel R. B., Irwin D. S., Craig W. A. and Welling P. G.: Bioavailability of chlorothiazide from 50 100 and 250 MG solution doses. Biopharm. Drug Dispos. 3: 89-94 (1982).
11. Adebayo, G. I. and Mabadeje, A. F.: Chlorothiazide absorption in humans-possible example of Michaelis-Menten kinetics. Pharmacology, 31: 181-188 (1985).
12. Hsu, F. H., Prueksaritanont, T., Lee, M. G. and Chiou, W. L.: The phenomenon and cause of the dose-dependent oral absorption of chlorothiazide in rats: extrapolation to human data based on the body surface area concept.J. Pharmacokinet. Biopharm., 15: 369-386 (1987).
13. Murakami, T. and Takano, M.: Intestinal efflux transporters and drug absorption. Expert Opin. Drug Metab. Toxicol., 4: 923-939 (2008).
14. Hasegawa, M., Kusuhara, H., Adachi, M., Schuetz, J. D., Takeuchi, K. and Sugiyama, Y.: Multidrug resistance-associated protein 4 is involved in the urinary excretion of hydrochlorothiazide and furosemide. J. Am. Soc. Nephrol., 18: 37-45 (2007).
15. www.drugbank.ca/drugs/DB00999.